Veracyte, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 5.80%

Veracyte, Inc. EBIT Margin is 5.80% for the Trailing 12 Months (TTM) ending March 31, 2025, a -130.44% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Veracyte, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was -19.04%, a 92.69% change year over year.
  • Veracyte, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was -9.88%, a -50.58% change year over year.
  • Veracyte, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was -20.00%, a -64.06% change year over year.
  • Veracyte, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was -55.64%, a 209.76% change year over year.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin